M. Garbrecht

807 total citations
38 papers, 593 citations indexed

About

M. Garbrecht is a scholar working on Oncology, Molecular Biology and Surgery. According to data from OpenAlex, M. Garbrecht has authored 38 papers receiving a total of 593 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 9 papers in Molecular Biology and 7 papers in Surgery. Recurrent topics in M. Garbrecht's work include Lymphoma Diagnosis and Treatment (4 papers), Medical Imaging Techniques and Applications (3 papers) and Acute Myeloid Leukemia Research (3 papers). M. Garbrecht is often cited by papers focused on Lymphoma Diagnosis and Treatment (4 papers), Medical Imaging Techniques and Applications (3 papers) and Acute Myeloid Leukemia Research (3 papers). M. Garbrecht collaborates with scholars based in Germany, Italy and United States. M. Garbrecht's co-authors include Christoph Fuchs, Markus Schwaiger, Wolfgang Römer, W. Enne, Christoph Nerl, Michael Herz, Sibylle Ziegler, Wolfgang Weber, R. Thödtmann and A. Suckel and has published in prestigious journals such as Circulation, Blood and European Journal of Biochemistry.

In The Last Decade

M. Garbrecht

31 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Garbrecht Germany 9 229 173 153 152 130 38 593
J.M. Cosset France 15 210 0.9× 128 0.7× 121 0.8× 262 1.7× 241 1.9× 43 814
T. Girinsky France 12 137 0.6× 128 0.7× 99 0.6× 90 0.6× 250 1.9× 22 574
Jackson Cundiff United States 10 244 1.1× 84 0.5× 102 0.7× 327 2.2× 258 2.0× 17 871
K. Breur Netherlands 16 268 1.2× 152 0.9× 222 1.5× 395 2.6× 245 1.9× 34 847
H.D. Kogelnik Austria 16 200 0.9× 119 0.7× 188 1.2× 253 1.7× 155 1.2× 31 789
Junpei Kuyama Japan 9 334 1.5× 167 1.0× 182 1.2× 230 1.5× 186 1.4× 20 637
M. V. Williams United Kingdom 11 129 0.6× 96 0.6× 184 1.2× 231 1.5× 186 1.4× 25 644
R Regnier Belgium 4 117 0.5× 120 0.7× 69 0.5× 218 1.4× 305 2.3× 15 581
Cosset Jm France 13 108 0.5× 69 0.4× 65 0.4× 168 1.1× 140 1.1× 50 447
Vittorio Donato Italy 15 183 0.8× 96 0.6× 72 0.5× 250 1.6× 156 1.2× 56 657

Countries citing papers authored by M. Garbrecht

Since Specialization
Citations

This map shows the geographic impact of M. Garbrecht's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Garbrecht with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Garbrecht more than expected).

Fields of papers citing papers by M. Garbrecht

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Garbrecht. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Garbrecht. The network helps show where M. Garbrecht may publish in the future.

Co-authorship network of co-authors of M. Garbrecht

This figure shows the co-authorship network connecting the top 25 collaborators of M. Garbrecht. A scholar is included among the top collaborators of M. Garbrecht based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Garbrecht. M. Garbrecht is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Garbrecht, M., et al.. (2008). Angioimmunoblastische Lymphadenopathie mit Dysproteinämie und sklerosierender Cholangitis. DMW - Deutsche Medizinische Wochenschrift. 119(10). 332–337.
2.
Dietel, Manfred, H. Arps, Axel Niendorf, et al.. (2008). Individualisierung der Chemotherapie durch prädiktive In-vitro-Bestimmung der Zytostatikasensitivität maligner Tumoren. DMW - Deutsche Medizinische Wochenschrift. 114(43). 1645–1652.
3.
Garbrecht, M., et al.. (2008). Ergebnisse eines modifizierten FAMeth-Chemotherapieprotokolls beim metastasierten Magenkarzinom. DMW - Deutsche Medizinische Wochenschrift. 114(37). 1391–1396.
5.
Stemmler, Hans‐Joachim, P Stieber, Andreas Schalhorn, et al.. (2003). Are Serial CA 19-9 Kinetics Helpful in Predicting Survival in Patients with Advanced or Metastatic Pancreatic Cancer Treated with Gemcitabine and Cisplatin?. Oncology Research and Treatment. 26(5). 462–467. 57 indexed citations
7.
Burlefinger, R, et al.. (1988). Common Variable Immunodeficiency Syndrome and Nodular Lymphoid Hyperplasia in the Small Intestine. Endoscopy. 20(5). 272–275. 48 indexed citations
8.
Hossfeld, D. K., et al.. (1987). Neutrophilic leukemia accompanied by hemorrhagic diathesis: Report of two cases. Annals of Hematology. 54(2). 109–113. 15 indexed citations
9.
Müllerleile, U., et al.. (1987). Incidence and Treatment of Fungal Infections in Neutropenic Patients. Hämatologie und Bluttransfusion. 30. 545–546. 1 indexed citations
10.
Garbrecht, M., et al.. (1986). Polychemotherapy with methotrexate in medium dose range, 5-fluorouracil and adriamycin in advanced gastric carcinoma. Journal of Cancer Research and Clinical Oncology. 111(S1). S85–S85. 2 indexed citations
11.
Garbrecht, M., et al.. (1986). Chemotherapy of metastatic malignant melanoma by cisplatin/ifosfamid or cisplatin / actinomycin d. Journal of Cancer Research and Clinical Oncology. 111(S1). S33–S33. 1 indexed citations
12.
Müllerleile, U., et al.. (1984). Prognostische Aussage des Serum-CEA und therapiebedingte unspezifische CEA-Verläufe beim metastasierenden Mammakarzinom. Oncology Research and Treatment. 7(6). 328–333. 1 indexed citations
13.
Wielckens, Klaus, et al.. (1980). ADP‐Ribosylation of Nuclear Proteins in Normal Lymphocytes and in Low‐Grade Malignant Non‐Hodgkin Lymphoma Cells. European Journal of Biochemistry. 104(1). 279–287. 33 indexed citations
14.
Garbrecht, M., et al.. (1979). Die Ausscheidung von normalen und modifizierten Nucleobasen im Urin bei chronischen myeloproliferativen Syndromen. Annals of Hematology. 38(5). 391–396. 7 indexed citations
15.
Leder, Lutz‐Dietrich, et al.. (1979). Terminal Ph1-positive monocytic crisis in chronic myeloid leukemia providing evidence for the promyelocytic origin of monocytes. Journal of Molecular Medicine. 57(5). 237–242. 12 indexed citations
16.
Stein, Elliot A., et al.. (1978). Abnormes Kontraktions- und Füllverhalten des linken Ventrikels bei Tumorpatienten unter Adriamycin-Therapie. DMW - Deutsche Medizinische Wochenschrift. 103(36). 1408–1412. 3 indexed citations
17.
Beckmann, H., et al.. (1974). Plasmazellkolonien aus leuk�mischem Knochenmark in vitro. Journal of Molecular Medicine. 52(12). 603–605. 2 indexed citations
18.
Beckmann, H., et al.. (1974). [Plasma cell colonies from leukaemic bone marrow in vitro. Differentiation by cytological and cytochemical methods (author's transl)].. Journal of Molecular Medicine. 52(12). 603–5. 1 indexed citations
19.
Garbrecht, M., et al.. (1974). DNA-dependent DNA and RNA polymerases and tRNA-methyl-transferases in human leukemia and differentiating Friend virus leukemia cells.. PubMed. 14. 256–69. 1 indexed citations
20.
Mertelsmann, Roland & M. Garbrecht. (1973). [DNA directed nucleic acid polymerases in normal and pathologic human leukocytes: differentiation, characterization and purification of DNA polymerases I, II and RNA polymerases A, B and their in vitro influence by cytostatics].. PubMed. 79. 550–4. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026